F. C. ERALDEMİR Et Al. , "Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity," 21. IFCC-EFLM Europen Congress of Clinical Chemistry and Laboratory Medicine. Paris, France. 21-25June 2015 , 2015
ERALDEMİR, F. C. Et Al. 2015. Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity. 21. IFCC-EFLM Europen Congress of Clinical Chemistry and Laboratory Medicine. Paris, France. 21-25June 2015 .
ERALDEMİR, F. C., ÇEKMEN, M. B., KELEŞ, M. E., ÖZSOY, Ö. D., MARAL KIR, H., VURAL, B., ... BAYDEMİR, C.(2015). Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity . 21. IFCC-EFLM Europen Congress of Clinical Chemistry and Laboratory Medicine. Paris, France. 21-25June 2015
ERALDEMİR, FATMA Et Al. "Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity," 21. IFCC-EFLM Europen Congress of Clinical Chemistry and Laboratory Medicine. Paris, France. 21-25June 2015, 2015
ERALDEMİR, FATMA C. Et Al. "Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity." 21. IFCC-EFLM Europen Congress of Clinical Chemistry and Laboratory Medicine. Paris, France. 21-25June 2015 , 2015
ERALDEMİR, F. C. Et Al. (2015) . "Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity." 21. IFCC-EFLM Europen Congress of Clinical Chemistry and Laboratory Medicine. Paris, France. 21-25June 2015 .
@conferencepaper{conferencepaper, author={FATMA CEYLA ERALDEMİR Et Al. }, title={Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity}, congress name={21. IFCC-EFLM Europen Congress of Clinical Chemistry and Laboratory Medicine. Paris, France. 21-25June 2015}, city={}, country={}, year={2015}}